Capmatinib

Ask supplier a question | View on supplier's website

Capmatinib is an orally bioavailable proto-oncogene c-Met (hepatocyte growth factor receptor [HGFR]) inhibitor with potential antitumor activity.

Supplier	Alfa Cytology
Product #	BC0383
Pricing	25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, 5.0 g, inquire

Feedback